Pekka Simula, M.Sc.

CEO of Herantis Pharma.

Pekka Simula is a board member of Sartar Therapeutics. Previously he was e.g. founding CEO of Oncos Therapeutics, Project Director at CRF Health, and Global Program Manager at Varian Medical Systems. He also served as board member of Oncos from 2009 until the company’s merger with Norwegian Targovax in 2015 and is the Chairman of Finnish Bioindustries.